Anti-GALNT8 antibodies are used in the immunodetection of the protein polypeptide N-acetylgalactosaminyltransferase 8. In humans, the canonical protein has a reported length of 637 amino acid residues and a mass of 72.9 kDa. Its subcellular localization is in the Golgi. It is widely expressed across many tissue types. A member of the Glycosyltransferase 2 protein family, GALNT8 is suspected to be catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include probable polypeptide N-acetylgalactosaminyltransferase 8, GalNAc transferase 8, UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase 8, and GALNAC-T8. GALNT8 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. Some GALNT8 antibodies may have been used in research and have associated citations. Indicated applications for the antibodies listed below include Western Blot, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry.